Print

Tanaka Precious Metals Succeeds in Development of High-sensitivity In-vitro Diagnostic Kit; Expected to Contribute to Early Discovery of Prostate Cancer  
9/7/2010 2:32:54 PM

Tokyo, Sept 3, 2010 (JCN Newswire) - Tanaka Holdings Co., Ltd. (Holding company of Tanaka Precious Metals, Head office: Marunouchi, Chiyoda-ku, Tokyo; President & CEO: Hideya Okamoto) today announced that Tanaka Kikinzoku Kogyo K.K. (Head office: Marunouchi, Chiyoda-ku, Tokyo; President & CEO: Hideya Okamoto), which operates the Tanaka Precious Metals's manufacturing business, succeeded in the development of a "high-sensitivity in-vitro diagnostic kit using colloidal gold" which the Japan Science and Technology Agency (Headquarters: Kawaguchi-shi, Saitama; President: Koichi Kitazawa; JST) had established as a development theme for the Risk-Taking Fund for Technology Development.
//-->